Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Revenue
2,204
2,227
2,066
2,089
1,902
1,646
Revenue Growth (YoY)
6%
8%
-1%
10%
16%
23%
Cost of Revenue
1,053
1,052
977
883
775
679
Gross Profit
1,150
1,175
1,088
1,205
1,127
967
Selling, General & Admin
628
626
569
504
438
363
Research & Development
324
326
343
349
291
232
Operating Expenses
953
951
894
857
730
596
Other Non Operating Income (Expenses)
0
1
44
14
51
-2
Pretax Income
168
193
240
412
403
339
Income Tax Expense
46
51
60
120
107
101
Net Income
120
141
178
290
293
236
Net Income Growth
-24%
-21%
-39%
-1%
24%
93%
Shares Outstanding (Diluted)
81.66
87.53
88.85
89.44
89.44
89.44
Shares Change (YoY)
-6%
-1%
-1%
0%
0%
0%
EPS (Diluted)
1.47
1.61
2.01
3.25
3.29
2.64
EPS Growth
-18%
-20%
-38%
-1%
25%
93%
Free Cash Flow
--
133
95
137
106
296
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
52.17%
52.76%
52.66%
57.68%
59.25%
58.74%
Operating Margin
8.89%
10.01%
9.39%
16.65%
20.82%
22.53%
Profit Margin
5.44%
6.33%
8.61%
13.88%
15.4%
14.33%
Free Cash Flow Margin
--
5.97%
4.59%
6.55%
5.57%
17.98%
EBITDA
--
349
326
422
465
432
EBITDA Margin
--
15.67%
15.77%
20.2%
24.44%
26.24%
D&A For EBITDA
--
126
132
74
69
61
EBIT
196
223
194
348
396
371
EBIT Margin
8.89%
10.01%
9.39%
16.65%
20.82%
22.53%
Effective Tax Rate
27.38%
26.42%
25%
29.12%
26.55%
29.79%
Follow-Up Questions
What are Carl Zeiss Meditec AG's key financial statements?
According to the latest financial statement (Form-10K), Carl Zeiss Meditec AG has a total asset of $3,403, Net profit of $141
What are the key financial ratios for CZMWF?
Carl Zeiss Meditec AG's Current ratio is 2.64, has a Net margin is 6.33, sales per share of $25.44.
How is Carl Zeiss Meditec AG's revenue broken down by segment or geography?
Carl Zeiss Meditec AG largest revenue segment is Ophthalmology, at a revenue of 1,723,707,000 in the most earnings release.For geography, EMEA is the primary market for Carl Zeiss Meditec AG, at a revenue of 657,500,000.
Is Carl Zeiss Meditec AG profitable?
yes, according to the latest financial statements, Carl Zeiss Meditec AG has a net profit of $141
Does Carl Zeiss Meditec AG have any liabilities?
yes, Carl Zeiss Meditec AG has liability of 1,286
How many outstanding shares for Carl Zeiss Meditec AG?
Carl Zeiss Meditec AG has a total outstanding shares of 87.53